Ben May Department for Cancer Research, the University of Chicago, Chicago, IL 60637, USA.
Wenzhou Medical University, Wenzhou, Zhejiang, China.
Exp Biol Med (Maywood). 2019 Nov;244(15):1313-1322. doi: 10.1177/1535370219864920. Epub 2019 Aug 9.
The cytoskeleton is an essential element of a eukaryotic cell which informs both form and function and ultimately has physiological consequences for the organism. Equally as important as the major cytoskeletal networks are crosslinkers which coordinate and regulate their activities. One such category of crosslinker is the spectraplakins, a family of giant, evolutionarily conserved crosslinking proteins with the rare ability to interact with each of the three major cytoskeletal networks. In particular, a mammalian spectraplakin isotype called MACF1 (microtubule actin crosslinking factor 1), also known as ACF7 (actin crosslinking factor 7), has been of particular interest in the years since its discovery; MACF1 has come under such scrutiny due to the mounting list of biological phenomena in which it has been implicated. This review is an overview of the current knowledge on the structure and function of the known spectraplakin isotypes with an emphasis on MACF1, recent studies on MACF1, and finally, an analysis of the potential of MACF1 to advance medicine.
Spectraplakins are a highly conserved group of proteins which have the rare ability to bind to each of the three major cytoskeletal networks. The mammalian spectraplakin MACF1/ACF7 has proven to be instrumental in many cellular processes (e.g. signaling and cell migration) since its identification and, as such, has been the focus of various research studies. This review is a synthesis of scientific reports on the structure, confirmed functions, and implicated roles of MACF1/ACF7 as of 2019. Based on what has been revealed thus far in terms of MACF1/ACF7’s role in complex pathologies such as metastatic cancers and inflammatory bowel disease, it appears that MACF1/ACF7 and the continued study thereof hold great potential to both enhance the design of future therapies for various diseases and vastly expand scientific understanding of organismal physiology as a whole.
细胞骨架是真核细胞的重要组成部分,它决定了细胞的形态和功能,最终对生物体产生生理影响。与主要细胞骨架网络同等重要的是交联剂,它协调和调节它们的活动。交联蛋白谱 plakins 就是交联蛋白的一个类别,是一类具有进化保守性的巨大交联蛋白,具有与三种主要细胞骨架网络中的每一种相互作用的罕见能力。特别是一种称为 MACF1(微管肌动蛋白交联因子 1)的哺乳动物谱 plakins 同种型,也称为 ACF7(肌动蛋白交联因子 7),自发现以来的几年里一直受到特别关注;由于它所涉及的越来越多的生物学现象,MACF1 受到了如此多的关注。这篇综述概述了已知谱 plakins 同种型的结构和功能的最新知识,重点介绍了 MACF1、最近对 MACF1 的研究,以及最后分析了 MACF1 推动医学发展的潜力。
谱 plakins 是一组高度保守的蛋白质,具有与三种主要细胞骨架网络中的每一种结合的罕见能力。哺乳动物谱 plakins MACF1/ACF7 自被鉴定以来,在许多细胞过程(如信号转导和细胞迁移)中被证明是必不可少的,因此一直是各种研究的焦点。这篇综述是对截至 2019 年 MACF1/ACF7 的结构、已证实的功能和所涉及作用的科学报告的综合。根据迄今为止在转移性癌症和炎症性肠病等复杂病理学中揭示的 MACF1/ACF7 的作用,MACF1/ACF7 及其进一步研究似乎具有很大的潜力,既能增强各种疾病未来疗法的设计,又能极大地扩展对整个生物体生理学的科学理解。